Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0AHAXH
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-SSTR2 ADC
|
|||||
| Synonyms |
Anti-SSTR2 Sulfo-SMCC DM1
Click to Show/Hide
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Meningiomas [ICD11:2A01]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.6
|
|||||
| Structure |
|
|||||
| Antibody Name |
Anti-human and mouse SSTR2 mAb (IgG1 kappa)
|
Antibody Info | ||||
| Antigen Name |
Somatostatin receptor type 2 (SSTR2)
|
Antigen Info | ||||
| Payload Name |
Mertansine DM1
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Sulfo-SMCC
|
Linker Info | ||||
| Conjugate Type |
The SulfoSMCC linker reacted with the 10 lysine residues of mAb, forming a stable amide bond.
|
|||||
| Combination Type |
Sulfo-SMCC-DM1
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.